WESPAC Advisors’s AbbVie ABBV Stock Holding History

WESPAC Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-12,720	Closed	-$1.9M	–	153
2023 Q3	$1.9M	Buy	12,720 +593	+5%	+$88.4K	1.42%	17
2023 Q2	$1.63M	Sell	12,127 -614	-5%	-$82.7K	1.31%	21
2023 Q1	$2.03M	Buy	+12,741	New	+$2.03M	1.91%	13
2022 Q4	–	Sell	-11,722	Closed	-$1.57M	–	64
2022 Q3	$1.57M	Sell	11,722 -5,341	-31%	-$717K	2.12%	11
2022 Q2	$2.61M	Buy	17,063 +7,690	+82%	+$1.18M	1.99%	11
2022 Q1	$1.52M	Sell	9,373 -5,220	-36%	-$846K	1.64%	17
2021 Q4	$1.98M	Buy	14,593 +156	+1%	+$21.1K	1.32%	16
2021 Q3	$1.56M	Buy	14,437 +8,256	+134%	+$890K	0.96%	30
2021 Q2	$696K	Sell	6,181 -7,134	-54%	-$803K	1.33%	26
2021 Q1	$1.44M	Sell	13,315 -3,845	-22%	-$416K	1.08%	25
2020 Q4	$1.84M	Buy	+17,160	New	+$1.84M	1.42%	10
2020 Q1	–	Sell	-15,555	Closed	-$1.38M	–	50
2019 Q4	$1.38M	Sell	15,555 -1,826	-11%	-$162K	1.35%	33
2019 Q3	$1.32M	Sell	17,381 -10,532	-38%	-$797K	1.31%	33
2019 Q2	$2.03M	Buy	+27,913	New	+$2.03M	1.51%	29
2019 Q1	–	Sell	-32,170	Closed	-$2.97M	–	126
2018 Q4	$2.97M	Buy	+32,170	New	+$2.97M	2.88%	3
2018 Q1	–	Sell	-18,466	Closed	-$1.79M	–	146
2017 Q4	$1.79M	Sell	18,466 -1,178	-6%	-$114K	1.66%	20
2017 Q3	$1.75M	Sell	19,644 -1,264	-6%	-$112K	1.15%	31
2017 Q2	$1.52M	Buy	20,908 +7,735	+59%	+$561K	1.04%	37
2017 Q1	$858K	Sell	13,173 -2,396	-15%	-$156K	0.99%	39
2016 Q4	$975K	Buy	15,569 +545	+4%	+$34.1K	1.09%	38
2016 Q3	$948K	Buy	15,024 +2,345	+18%	+$148K	1.07%	37
2016 Q2	$785K	Buy	+12,679	New	+$785K	0.81%	44
2015 Q3	–	Sell	-40,028	Closed	-$2.69M	–	65
2015 Q2	$2.69M	Buy	40,028 +4,394	+12%	+$295K	2.02%	10
2015 Q1	$2.09M	Buy	35,634 +610	+2%	+$35.7K	1.58%	19
2014 Q4	$2.29M	Buy	35,024 +5,691	+19%	+$372K	1.61%	19
2014 Q3	$1.69M	Buy	+29,333	New	+$1.69M	1.36%	22
2014 Q1	–	Sell	-16,095	Closed	-$850K	–	135
2013 Q4	$850K	Buy	16,095 +9,479	+143%	+$501K	0.71%	61
2013 Q3	$296K	Buy	+6,616	New	+$296K	0.35%	94